AntagomiR-based therapy for Hepatic Steatosis: MiRNA-92 aggravates hepatic steatosis via down regulation of its target gene, 23/August/2014, 05.09 am

AntagomiR-based therapy for Hepatic Steatosis: MiRNA-92 aggravates hepatic steatosis via down regulation of its target gene, 23/August/2014, 05.09 am

AntagomiR-based therapy for Hepatic Steatosis: MiRNA-92 aggravates hepatic steatosis via down regulation of its target gene, 23/August/2014, 05.09 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, AntagomiR-based therapy for Hepatic Steatosis: MiRNA-92 aggravates hepatic steatosis via down regulation of its target gene, 23/August/2014, 05.09 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

* Research cooperation